Moderate Evidence
Research Overview
GHRP-6 Research for Cachexia/Wasting
An evidence-based overview of research examining GHRP-6 in the context of cachexia/wasting. This page synthesizes findings from peer-reviewed literature.
Research Summary
GHRP-6's strong appetite-stimulating effects via ghrelin receptor activation suggest potential utility in wasting conditions. However, the more selective anamorelin (approved in Japan) has largely superseded GHRP-6 for cachexia research.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cachexia/Wasting
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. GHRP-6 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.